UCB (Indian Unit) Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 450
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

UCB (Indian Unit) General Information

Description

Provider of pharmaceutical products. The unit provides drugs used for the treatment of allergies, epilepsy and respiratory disorders

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Dr. Reddy's Laboratories
Primary Office
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UCB (Indian Unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore UCB (Indian Unit)‘s full profile, request access.

Request a free trial

UCB (Indian Unit) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UCB (Indian Unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore UCB (Indian Unit)‘s full profile, request access.

Request a free trial